Physician profile
Robert L Scott
NPI 1659354652
$106,191.46
in general payments reported to CMS, 2019-2025
12 companies · $22K in 2025
The $22K reported for 2025 was more than what 97% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $130 · 2021: $209 · 2022: $413 · 2023: $37K · 2024: $20K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $70K · Travel and Lodging: $7,127 · Food and Beverage: $2,419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $70,068.00 |
| Travel and Lodging | $7,127.45 |
| Food and Beverage | $2,419.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $94,789.06 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Bayer Healthcare Pharmaceuticals INC. | $9,982.13 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $716.00 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $183.23 | 2019-2020 | |
| United Therapeutics Corporation | $145.92 | 2023-2024 | Tyvaso |
| Abbott Laboratories | $126.82 | 2019-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Edwards Lifesciences Corporation | $125.76 | 2021 | |
| Novo Nordisk INC | $101.60 | 2022 | |
| Inspire Medical Systems, INC. | $20.94 | 2025 | Inspire |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.